AI Summary

Chronic kidney disease (CKD) affects a significant portion of the global population, with approximately 850 million people worldwide impacted. The condition has been steadily increasing over the past 20 years, and current treatments, such as RAAS inhibitors and angiotensin receptor blockers, have varying levels of effectiveness. Research suggests that cannabinoid pathways may offer potential targets for addressing CKD, providing a new area of exploration for treatment options.

AI summaries can be wrong sometimes—always verify important details using the source article.